These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 21628592)

  • 1. In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging.
    Eser S; Messer M; Eser P; von Werder A; Seidler B; Bajbouj M; Vogelmann R; Meining A; von Burstin J; Algül H; Pagel P; Schnieke AE; Esposito I; Schmid RM; Schneider G; Saur D
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9945-50. PubMed ID: 21628592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.
    Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD
    Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopy.
    Li H; Li Y; Cui L; Wang B; Cui W; Li M; Cheng Y
    PLoS One; 2014; 9(9):e106566. PubMed ID: 25184278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.
    Neesse A; Hahnenkamp A; Griesmann H; Buchholz M; Hahn SA; Maghnouj A; Fendrich V; Ring J; Sipos B; Tuveson DA; Bremer C; Gress TM; Michl P
    Gut; 2013 Jul; 62(7):1034-43. PubMed ID: 22677720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of pancreatic cancer precursor lesions in IHC-stained tissue with a tissue image analysis platform.
    Aeffner F; Martin NT; Peljto M; Black JC; Major JK; Jangani M; Ports MO; Krueger JS; Young GD
    Lab Invest; 2016 Dec; 96(12):1327-1336. PubMed ID: 27775692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
    Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
    APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice.
    von Burstin J; Eser S; Seidler B; Meining A; Bajbouj M; Mages J; Lang R; Kind AJ; Schnieke AE; Schmid RM; Schneider G; Saur D
    Int J Cancer; 2008 Nov; 123(9):2138-47. PubMed ID: 18709639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
    Haugk B
    Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.
    Hanoun N; Delpu Y; Suriawinata AA; Bournet B; Bureau C; Selves J; Tsongalis GJ; Dufresne M; Buscail L; Cordelier P; Torrisani J
    Clin Chem; 2010 Jul; 56(7):1107-18. PubMed ID: 20431052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
    Iakovlev V; Siegel ER; Tsao MS; Haun RS
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
    du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
    Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer.
    Jiang SH; Liu D; Hu LP; Zhang S; Yu Y; Sun YW; Ji J; Zhang ZG
    EBioMedicine; 2022 Jun; 80():104050. PubMed ID: 35561453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer.
    Ringel J; Löhr M
    Mol Cancer; 2003 Jan; 2():9. PubMed ID: 12556240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.
    Kim J; Hoffman JP; Alpaugh RK; Rhim AD; Reichert M; Stanger BZ; Furth EE; Sepulveda AR; Yuan CX; Won KJ; Donahue G; Sands J; Gumbs AA; Zaret KS
    Cell Rep; 2013 Jun; 3(6):2088-99. PubMed ID: 23791528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
    Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
    Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.